Member Info for scardey_cat

Braveheart dump well underway now, surprise, surprise.

Was wondering why the price hadn't changed for the last 50 hours or so Doggy. Cheers, I can switch off now :-)

Keep thinking back to our ODX man working on the Avacta test. Doing some TT prep perhaps? There has to be more to this than meets the eye.

Rolly, have you considered leaving a tad more than 10 quid as your 'available' amount in your spread bet/CFD account?

Porche: I had a slight issue adding £2ml on Friday, but it went through in the end. Can't tell you what I bought with it :-)

COYS: Pretty sure AS referred to Spain and UK in one of the recent interviews.

MB:
"In December 2020, a call out was made to UK Academic Institutions advising that a consortium of UK lateral flow providers, contract research and manufacturing partners is collaborating to deliver a high capacity pipeline of novel lateral flow tests for SARS-2 COVID-19 infectiousness (antigen tests) which may be used during the current pandemic. This second call is for partners to provide more materials for evaluation but specifically for Nucleocapsid protein detection."

So, the first callout was predominantly for 'S' and having had insufficient response for 'N' they make a second callout for 'N'. Don't think you can infer anything about their preference for either from this.

Anyway, when the dynamic duo Avacta/Mologic come up with the ultimate S/N test, these nuances will all be irrelevant.

Or, more simply:

1 - primary monoclonal viral epitope recognition antibodies,
2 - affimers,
3 - carbohydrates or others to nucleocapsid epitopes
4 - and also paired capture antibodies for the primary.

MB, to me that paragraph reads:

"The consortium seeks novel, high affinity molecule pairs made up;
primary monoclonal viral epitope recognition antibodies,
affimers,
carbohydrates or others to nucleocapsid epitopes
and also paired capture antibodies for the primary."

That is, the first part of the requirement "primary monoclonal viral epitope recognition antibodies, affimers" relates to 'S' protein and the "carbohydrates or others to nucleocapsid epitopes" relates to 'N' protein. So, they are seeking both, not just 'N'.

Think I'll give IG level 2 a try Ozaztec. I really like IG's platform. I'll order a 'Level 2 for Dummies' book to go with it.

That's very interesting Parker. A handful of small ABDX trades all day, then an £82k buy at the death. You might be on to something. Been waiting for that to wake up!

Cheers both. I think I'll give that a go. I assume, though, it wouldn't show you the buy order for 2 million obviously?

Just look at those delayed trades. Incredible how reporting of delayed trades is allowed in this way. Can't think of a credible reason for it. Just seems to offer the MM's a way of hoodwinking pi's. Is there a platform where you can see trades in real time, rather how we see it here? Even if it was a paid for service, it would be well worth it.

Well, the market's not too excited about it...TTG 4.5% up, that must tell you something.

I'd be surprised if AS disappoints on the timeline for CE/CV. He will know he's under the spotlight delivery time wise, so I half expect an early delivery on this one. What will be interesting is the study size. If it's in the region of 1000 negative + 200 positive, it might tell us that he has one eye on the 'equivalent' Porton Down phase 3a evaluation, talked about in the £8bn framework.

Sang, I already complained to my mum, but she told me to stop being a softy.

My 'fill or kill' was a sell Matt. Needless to say, didn't get executed.

Very optimistic... -50% bloody hell.

Got my 'fill or kill' in at 103. Might be being a bit optimistic with my limit though.

Soz, uamalik1, hope you didn't mind me borrowing your post :-)